{"acute respiratory distress syndrome": 2.21, "anaphylactic reaction": 3.47, "anaphylactoid reaction": 9.5, "anti factor viii antibody positive": 19.11, "autoimmune haemolytic anaemia": 15.21, "bacteraemia": 4.02, "blood immunoglobulin g decreased": 35.15, "cardiogenic shock": 2.59, "chronic hepatitis b": 69.89, "coombs direct test positive": 105.69, "coronary artery aneurysm": 127.02, "cytomegalovirus infection": 4.39, "deep vein thrombosis": 2.4, "drug effective for unapproved indication": 113.33, "drug ineffective": 6.73, "drug ineffective for unapproved indication": 128.88, "drug intolerance": 3.17, "drug resistance": 7.21, "dyshidrotic eczema": 25.92, "ear infection": 4.39, "embolism": 4.53, "epstein-barr virus infection": 6.17, "exposure during pregcy": 7.67, "febrile nonhaemolytic transfusion reaction": 84.71, "foetal death": 5.8, "foetal exposure during pregcy": 4.87, "guillain-barre syndrome": 2.18, "haemolysis": 44.42, "haemolytic anaemia": 42.03, "hepatitis b": 33.0, "hepatitis b core antibody positive": 54.2, "hepatitis b surface antibody positive": 64.46, "hepatitis c": 9.59, "hypervolaemia": 4.5, "hypoxia": 4.05, "incorrect drug administration rate": 12.96, "infusion related reaction": 4.86, "infusion site erythema": 10.89, "infusion site pain": 8.23, "intentional product use issue": 13.17, "ischaemic stroke": 2.39, "jaundice": 2.06, "low birth weight baby": 3.88, "maternal exposure during pregcy": 4.13, "meningitis": 3.34, "meningitis aseptic": 104.76, "misleading laboratory test result": 460.29, "myositis": 2.96, "nephrotic syndrome": 2.6, "no adverse event": 36.18, "off label use": 7.57, "photophobia": 2.05, "posterior reversible encephalopathy syndrome": 24.16, "premature baby": 5.84, "premature delivery": 4.42, "product use in unapproved indication": 7.22, "pulmonary embolism": 2.52, "respiratory failure": 2.16, "stress cardiomyopathy": 5.43, "suspected counterfeit product": 7.44, "tachypnoea": 4.18, "therapeutic product effect incomplete": 28.16, "therapeutic response decreased": 2.04, "therapeutic response unexpected": 12.16, "therapy non-responder": 18.4, "therapy partial responder": 16.74, "transfusion-related acute lung injury": 208.08, "transfusion-related circulatory overload": 135.55, "treatment failure": 2.85, "vertical infection transmission": 793.83}